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Abstract: Most organisms experience changes in regenerative abilities through their 
lifespan. During aging, numerous tissues exhibit a progressive decline in homeostasis and 
regeneration that results in tissue degeneration, malfunction and pathology. The mechanisms 
responsible for this decay are both cell intrinsic, such as cellular senescence, as well as  
cell-extrinsic, such as changes in the regenerative environment. Understanding how these 
mechanisms impact on regenerative processes is essential to devise therapeutic approaches 
to improve tissue regeneration and extend healthspan. This review offers an overview of 
how regenerative abilities change through lifespan in various organisms, the factors that 
underlie such changes and the avenues for therapeutic intervention. It focuses on 
established models of mammalian regeneration as well as on models in which regenerative 
abilities do not decline with age, as these can deliver valuable insights for our 
understanding of the interplay between regeneration and aging. 
Keywords: aging; regeneration; senescence; stem cells; reprogramming; newt; axolotl; 
zebrafish; planaria 
 
1. Introduction 
From the onset of development until the end of their lifespan, most organisms experience a 
progressive decline in their regenerative abilities. From a biological perspective, regeneration can be 
subdivided into the ability to replace lost or damaged cells, which includes tissue turnover and limited 
injury responses found in the majority of organisms including mammals, and the ability to regenerate 
complex structures, which is mostly absent in mammals but finds expression in a number of other 
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animals. During aging, mammals exhibit changes in their ability to regenerate vital biological 
structures such as the vascular, nervous, muscular, haematopoietic and skeletal systems as well as 
many organs and cell types, which correlate with the overall organismal decay. Although metazoan 
species exhibit a diverse range of lifespans, it is notable that in most organisms studied so far there is a 
strong association between the decline in regenerative capacity and the aging process. Indeed, it has 
been proposed that aging results from the inability to maintain proper tissue structure and function due 
to insufficiencies in regenerative capacity [1]. Hence, regeneration and aging could represent two sides 
of the same coin. This idea is supported by the existence of organisms with extreme regenerative 
capacities, such as planarians and salamanders, which exhibit negligible signs of aging, as indicated by 
the lack of measurable functional declines with age [2]. 
The principles that underlie the decline in regenerative abilities through lifespan are currently being 
unravelled. However, it is already clear that both cell-intrinsic (such as cellular senescence) as well as 
cell-extrinsic factors (such as alterations in the regenerative environment) play significant roles. Notably, 
these factors show extensive overlap with those known to underlie the aging process [3], highlighting the 
interconnection between aging and regeneration and stressing that therapeutic approaches designed towards 
enhancement of regenerative abilities could also result in considerable health/lifespan improvements. 
This review discusses the nature of the changes in regenerative abilities that take place through 
lifespan and across phylogeny, the factors which underpin such changes and the avenues for 
therapeutic interventions which leverage off this body of research. A particular emphasis is placed on 
knowledge derived from the classic regeneration models, organisms capable of extensive regeneration 
of complex structures in which age related declines in regenerative abilities are not observed, as this 
can shed light on important mechanisms with potential therapeutic application. 
2. Changes in Regenerative Ability through Phylogeny, Ontogeny and Aging 
The ability to regenerate tissues, organs and body structures varies drastically across the animal 
kingdom (Figure 1). This variation ranges from the ability to execute whole body regeneration found 
in Hydra and freshwater planarians, through the extensive abilities to regrow complex structures found 
in vertebrates such as teleost fishes (e.g., zebrafish) and salamanders (e.g., newts and axolotls), to the 
more limited regeneration capacities found in mammals. Furthermore, within a particular organism, 
these abilities may vary according to the nature of the tissues and the age of the organism. Studies in 
several regeneration systems have uncovered two important overall trends. First, tissue regeneration 
tends to be high during early life stages, and various regenerative time-windows have been defined 
through ontogenesis [4]. Second, there is a progressive decline in regenerative abilities during aging. 
These tendencies are valid for many organisms, including mammals. However, there are interesting 
exceptions, which include the classic models of regeneration such as planarians, zebrafish and salamanders. 
Schematic depiction of changes in regenerative capacity at different life stages (development, early 
and late adulthood) in representative organisms. From top to bottom: mammals (human, mouse, deer), 
birds (chicken), fish (zebrafish/killifish), amphibians (frog, salamander (newts and axolotls)), 
Platyhelminthes (planarian flatworm) and cnidarians (hydra). Whereas a progressive decline in regenerative 
abilities is characteristic of mammalian aging, classical regeneration models such as hydra, planarians, 
zebrafish and salamanders exhibit extensive and time resistant abilities to regenerate complex structures. 
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Figure 1. Variation in regenerative capacity through phylogeny, ontogeny and aging.  
* Note that the ability to regenerate the indicated systems is present in most other animal 
groups; ** Lens regeneration is observed throughout lifespan in newts, but it can only 
occur during a limited developmental window in axolotls. 
2.1. Variations during Development 
Ontogenetic changes in regenerative capacity occur in many physiological systems, including heart, 
spinal cord, digit tips and hair cells (Figure 1). For example, mammals have the ability to regenerate 
their hearts until shortly after birth, when this ability is lost [5]. In addition, they are only able to 
regenerate their spinal cords during early development (and then only partially), in common with other 
organisms such as birds and frogs [6]. 
Among the cell types whose regeneration is affected by the developmental stage, auditory hair cells 
constitute a well-characterised example. In contrast to salamanders, birds and fish, which can 
regenerate their hair cells through adulthood [7], in mammals this is only possible during development [8]. 
Inter and intra-species comparative experiments suggest that fluctuations in key developmental 
regulators such as retinoic acid and growth factors underlie changes in hair cell regenerative capacity [8]. 
Ontogenetic changes also underlie the ability to regenerate digit tips in mice and humans, as this 
ability drastically decreases after development. Foetal digit tip regeneration is rapid and completed by 
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birth, whereas neonatal digit tip regrowth takes considerably longer and occurs with imperfections [9,10].  
In a more striking example, frogs are able to regenerate full limbs prior to metamorphosis, however 
after this process they are only capable of regenerating their digits. Indeed, post-metamorphic changes 
in frogs are dramatic, affecting their ability to regenerate not only limbs and spinal cord but also their 
heart, skin and lens [4]. Interestingly, extending the time a frog spends as a larva leads to increases in 
its ability to regenerate the spinal cord [11]. This suggests that the hormonal or structural alterations 
brought about by metamorphosis could impact on the ability to regenerate certain tissues. However, 
there are other examples among amphibians that do not seem to be related to metamorphosis-induced 
changes, such as the case of the axolotl lens, which can only be regenerated for a period of two weeks 
after hatching [12]. 
Although the factors that determine these ontogenetic changes remain unknown, it is possible that 
the growth stimuli and high cellular plasticity levels associated with developmental processes 
contributes to the generation and instruction of regenerative progenitors, creating a permissive 
regenerative environment during development. As the structure, physiology and environmental exposure 
of an organism changes from development to adulthood, it is likely that changes in regenerative capacity 
that occur late during lifespan are driven by different factors than those operating during development. 
2.2. Variations during Aging 
Aging is associated with defects in tissue regeneration and repair that lead to cell loss and 
compromise of tissue homeostasis, structure and function. This is particularly well documented in 
mammals, whose regenerative functions predominantly rely on tissue-specific stem cells (cells with the 
ability to self-renew and produce daughter cells that differentiate into particular cell types), and in 
some cases on restricted progenitor cells (cells which can undergo cell division despite a degree of 
maturation). With age, both stem and progenitor cells undergo a series of alterations including loss of 
self-renewal capacities, altered proliferative activity, declines in functionality and potency. These 
changes have been shown to contribute to the degeneration and dysfunction of a number of tissues and 
systems including blood, muscle, bone, cartilage, the central nervous system (CNS), organs such as the 
pancreas, and most epithelia and endothelia [13,14]. 
The regenerative capacity in the skeletal muscle system experiences a marked decline with age in 
many organisms, as reflected by a decrease in the generation of myofibres and an increase in fibrotic 
tissue upon muscle injury [13,15]. In humans, this is an underlying cause of sarcopenia, the loss of 
muscle mass that accompanies aging. The decline in muscle regenerative potential is largely attributed 
to changes in satellite cells, the muscle stem cells, which undergo age-related declines in proliferative 
and myogenic capacities. Indeed, satellite cell numbers decline gradually in mammalian muscles with 
advancing age [16]. As discussed in the next section, these changes seem to be the result of both  
cell-intrinsic as well as extrinsic alterations such as aging of the muscle environment. 
In mammalian species, age-related declines in immune responses, increase in leukaemia incidence 
and normocytic anaemia are associated with a decline in regenerative potential of haematopoietic stem 
cells (HSC) [17]. Age-related changes in HSC include decreases in functionality, changes in cell cycle 
kinetics and skewed differentiation towards myeloid lineages [18–21]. 
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Age-specific changes have also been reported for mesenchymal stem cells (MSC), stromal cells that 
can differentiate into multiple cell types such as osteblasts, condrocytes and adipocytes. Alterations 
include a loss in chondrogenic potential leading to impaired chondrocyte formation, which results in 
decreased cartilage repair in aged mammals [22]. Furthermore, studies in human-derived bone marrow 
MSC revealed age-dependent decreases in their capacity to differentiate to osteoblasts, which are 
related to increases in the level of MSC apoptosis and senescence upon aging [23,24]. Together, these 
alterations contribute to conditions such as osteoporosis and reduced bone repair capacity that are 
characteristic of human aging [23]. 
In mammals, the extent of adult neurogenesis also declines with age. In humans and mice, adult 
neurogenesis occurs in the hippocampus and the olfactory bulb [25]. De novo neurogenesis takes place 
from neural stem cells (NSC), and these have been shown to decline with age, resulting in significant 
decreases in regenerated neurons and hence functional impairment [13]. Factors that underlie such 
defects include reduced stem cell proliferation and increased apoptosis in the regenerated neuronal 
progeny [26]. Furthermore, age also affects regeneration of peripheral nerves, as exemplified by the 
loss of taste bud regeneration in old mice as a result of impaired recovery from gustatory nerve injury [27]. 
This is an interesting example of nerve dependence in regeneration, an important phenomenon which 
should also be considered in the context of changes in regenerative abilities upon aging (see discussion 
in the Section 3.7). 
Pancreatic β cells, the key centres of insulin production, storage and release, constitute a clear 
example of age-dependent alterations in regenerative capacity. In both humans and mice, pancreatic  
β cells increase in number (upon physiological or regenerative stimuli) largely through compensatory 
proliferation [28], although transdifferentiation from pancreatic α and δ cells has also been reported in 
cases of extensive β cell loss in mice [29,30]. With age, β cell turnover capacities decline drastically [31]. 
This has been associated with changes in key cell-cycle regulators, such as the epigenetic derepression 
of p16ink4a, as well as the activation of p38 kinase [32,33]. Interestingly, recent studies in mice suggest 
that, concomitantly with a decline in replicative potential, there is an improvement of β cell functions 
such as insulin-secretion with aging, highlighting that aging does not always result in declines of 
cellular function [34]. 
As mentioned, aging also affects the regenerative capacity of progenitor cells. Age-related changes 
in endothelial progenitor cells (EPC), circulating progenitors with an endothelial phenotype that 
contribute to the regeneration and repair of vessel walls, have been reported. Although there is no 
change in the number of EPC with age, deficits in cell function are apparent during aging [35]. In mice, 
this has been associated with the development of atherosclerosis, a common disease of old age [36]. 
2.3. The Exceptions to the Rule 
While the aforementioned observations are true for most organisms studied so far, this is not valid 
for a number of organisms, the classic regeneration models, such as hydra, planarians, zebrafish and 
salamanders (Figure 2). Not only do they exhibit the most extensive regenerative abilities in the natural 
world, but also these abilities remain intact throughout their lifespan. 
Two remarkable organisms, the freshwater cnidarian hydra and the planarian flatworm represent the 
most extreme case, as they are able to regenerate whole bodies from a single fragment [37–39]. 
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Interestingly, this type of regeneration is based on stem cells with a high level of plasticity, and 
constitutes the basis for the asexual reproduction strategy used by these organisms. In the case of 
planarians, their remarkable regenerative abilities led to the conclusion that they may “almost be called 
immortal under the edge of the knife” [40]. Studies on these models raise the question of what factors 
underlie their impressive regenerative capabilities and to what extent this knowledge could be 
translated to mammals. 
Perhaps even more remarkably, examples of high and time-resistant regenerative abilities are found 
among vertebrates. This includes the zebrafish, which is able to regenerate complex structures such as 
parts of its heart and brain, barbels, fins and spinal cord [41,42]. Notably, detailed studies in young and 
old individuals have revealed that the ability to regenerate the caudal fin, the barbels and the heart does 
not decrease with age [43,44] or repetitive regeneration cycles [44–46] although age and sex-related 
differences do affect regeneration of the pectoral fin [47]. 
 
Figure 2. Regeneration of complex structures in classic regeneration models. (A) Regeneration 
of a hydra polyp following amputation across the body stalk. Regeneration takes place 
through mobilisation and activation of multipotent endodermal and ectodermal stem cell 
populations; (B) Regeneration of a planarian flatworm following bisection. This process 
takes place through recruitment of pluripotent stem cells, termed “neoblasts”, which are 
present throughout the animal and carry out tissue maintenance functions. A single 
clonogenic neoblast is capable of regenerating an entire organism; (C) Regeneration of the 
zebrafish fin. Upon amputation of the fin, differentiated cells at the amputation plane 
undergo dedifferentiation and proliferate to form a pool of progenitors called a blastema, 
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which will then undergo growth and redifferentiation into the new fin tissues; (D) 
Salamander limb regeneration depends, as in the zebrafish case, on the dedifferentiation of 
mature cells from the tissues at the amputation plane. Unlike the zebrafish fin, which 
grows continuously, salamander regeneration takes place in the context of mature adult 
tissues. Both in zebrafish and salamanders, the dedifferentiation process generates 
progenitors of limited potential, which can only regenerate their tissues of origin. The wound 
epithelium, nerve supply and macrophages are critical components of the regenerating niche, 
without which regeneration cannot proceed. Adapted from Brockes et al. [48]. 
Extensive regenerative abilities are also found in the salamanders, such as newts and axolotls. 
Among vertebrates, these organisms are considered the champions of regeneration, as they are able to 
regrow a wide range of structures including parts of their heart and brain, jaws, entire tails (including the 
spinal cord), lens and hair cells, and they are the only vertebrate able to regenerate full limbs in the adult 
stage [48,49]. Notably, whereas regeneration in hydra, planarians and zebrafish takes place in 
organisms that are constantly growing or undergoing high turnover, which could be an important 
precondition of their regenerative abilities [42], salamander regeneration operates in the context of an 
organism that has reached its maturation stage. In these organisms, regeneration of complex structures 
takes place through reprogramming of differentiated cells, proliferation, and subsequent redifferentiation 
of adult tissues [48,50], although transdifferentiation and stem-cell based regeneration are also used in 
certain contexts [51,52]. Importantly, their ability to regenerate their limbs or spinal cords does not 
decline with repetitive amputations [53], suggesting that these organisms have an unlimited regenerative 
potential for regenerating complex structures. Indeed, these observations are supported by a recent 
study on lens regeneration, which suggests that regenerative capacity in newts is not altered by 
repeated regeneration and aging [51]. 
Together, these organisms demonstrate that attaining perfect regeneration even during old age is 
possible, although the mechanisms that underlie such unlimited regenerative capacities remain 
unknown. Recent technological advances (e.g., transgenesis, development of RNA sequencing 
technologies) have transformed many of these organisms into valuable, tractable models in which to study 
the factors and mechanisms that impact on the decay or resistance of regenerative capacity upon aging. 
3. Factors that Affect Regenerative Capacity during Aging 
A number of cellular and molecular mechanisms have been associated with the decline in 
regenerative abilities observed during aging in humans and various model organisms (Figure 3). 
Unsurprisingly, most of these mechanisms have also been shown to be important contributors to the 
aging process and form part of the recently defined Hallmarks of Aging [3]. These include intrinsic 
factors such as genomic instability (including telomere attrition), mitochondrial dysfunction, 
epigenetic changes, loss of proteostasis and metabolic alterations, as well as cell extrinsic factors such 
as disruption of the regeneration niche and alterations in systemic signals. Though most of these 
factors can contribute to age-related impairment in regenerative capacity, a consensus on their relative 
importance in this process is currently lacking. Furthermore, emerging evidence suggests a high degree 
of interconnectivity between them, stressing the importance of identifying the common denominators 
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which will help us define the underlying causes of the decline in regenerative abilities upon aging and 
derive successful therapeutic strategies. 
 
Figure 3. Factors that alter regenerative capacity upon aging. Multiple cell-intrinsic and  
cell-extrinsic factors are associated with the decline of regenerative capacity during aging 
(left). These impact on regenerative cell types by altering key cellular processes (middle), 
leading to various negative outcomes that result in regeneration impairment (right). * Cell 
senescence can be considered an intrinsic and, potentially, extrinsic factor (see Section 4). 
3.1. Genomic Instability 
In the majority of cases, the process of regeneration relies on cells with long-term capacity for  
self-renewal. While this characteristic is key for their ability to promote regenerative processes through 
lifespan, it also increases the possibility of acquiring DNA damage as a result of replicative stress, 
including from telomere erosion (discussed below) as well as internal and external mutagens  
(e.g., reactive oxygen species (ROS) and UV light exposure respectively). Indeed, various studies have 
shown a marked accumulation of DNA damage with age in mammalian stem cells [21,54–57]. This 
poses important challenges, as these genotoxic lesions could impact on gene function, leading to 
alterations in differentiation and self-renewal capacities, and promote neoplastic transformations 
resulting in increased cancer risk. In addition, somatic mutations could affect cells within the 
regenerative niche, leading to functional impairments that affect the regeneration outcome. 
To counteract such threats the cells rely on a sophisticated DNA damage response machinery, 
which allows detection and repair of various types of DNA damage through mechanisms such as 
mismatch repair, nucleotide excision repair, non-homologous or microhomology-mediated end joining, 
and homologous recombination. This network also includes checkpoint mechanisms that promote 
transient cell cycle halts for the repair of genotoxic lesions and ensures that such repair has been 
carried out. When the damage is too extensive or cannot be repaired, this machinery leads to the 
elimination via apoptosis, or permanent cell cycle arrest via cellular senescence, of the compromised 
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cells. In the context of regeneration, this can result in depletion of stem/progenitor cell pools [58], loss of 
stem cell quiescence [59], premature differentiation [60] and, when the checkpoint mechanisms fail and 
the DNA damage remains, neoplastic transformation. 
The importance of the maintenance of genomic stability for regenerative processes is further 
highlighted by the fact that many mutations that disrupt the ability of cells to detect and repair DNA 
damage result in impaired regenerative capacity in various tissues. These include mutations in the 
DNA damage sensor ATM and in the RecQ DNA helicases, which lead to the Ataxia Telangiectasia 
and the Werner, Blood and Rothmund-Thompson progeroid syndromes respectively (human diseases  
that recapitulate some aspects of chronological aging) [61]. In particular, mesenchymal stem cells 
reprogrammed from Werner syndrome patients exhibit premature cellular senescence [62]. 
Additionally, DNA repair defects such as those found in cells derived from Fanconi anemia patients 
(which have defects in crosslink repair and homologous recombination proteins) can predispose cells 
to catastrophe during proliferation bursts, as shown in the case of haematopoietic stem cells which 
undergo cell death following physiological challenges such as substantial blood loss. 
In mice, genetic disruption of ATM or another DNA damage sensor, ATR, causes significant  
age-dependent perturbation in stem cell compartments. Furthermore, stem cells from mouse models 
deficient in DNA repair pathways such as non-homologous end joining, crosslink and nucleotide excision 
repair show diminished self-renewal, increased apoptosis and functional exhaustion with age [21,58].  
In addition, defective DNA repair mechanisms have been shown to sensitise hair-follicle melanocyte 
stem cells to undergo premature differentiation, leading to stem cell pool depletion and accelerated hair 
greying [63]. 
The extent to which these repair mechanisms can affect regenerative progenitors depends on the 
nature of the mechanism and cell-cycle status of the cell. For example, in many organisms the 
maintenance of pools of quiescent cells is critical for regenerative capacity. However, this requirement 
ironically contributes to the damage or depletion of these cells as the quiescent state, with its single set 
of chromatids, precludes the use of accurate forms of DNA repair (such as homologous recombination) 
and promotes error-prone non-homologous end joining [64]. In the case of aging hematopoietic stem 
cells, this has recently been shown to result in a quiescent-dependent and marked accumulation of 
DNA damage coinciding with a broad attenuation of DNA repair and response pathways [65]. 
Therefore, the interplay between cell cycle status and DNA repair pathways can impact the extent of 
increased genomic instability with age, which in turn has consequences for regenerative capacity. 
Recently, various studies have found age-dependent abnormalities in expression of DNA repair  
genes [65,66], which correlate with defects in stem cell functionality. Interestingly, recent gene 
expression analysis during lens regeneration in adult newts, a process unaffected by aging, revealed an 
upregulation of DNA repair genes during regeneration [14,67]. This could represent a strategy to 
minimise genomic instability, promoting accurate regeneration even at an advanced age, something 
which should be explored in further studies. 
In addition to age-related changes in the expression or activity of DNA repair genes, the expression 
of DNA replication genes can also change during aging, leading to further genomic compromise 
derived from replicative stress [54]. A comparison between young and old HSCs recently uncovered a 
decrease in expression of MCM4 and MCM6 (part of a helicase complex essential for replication) 
upon aging, coinciding with persistent DNA damage. Such damage was particularly apparent in 
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ribosomal DNA genes, known to be sensitive to replicative stress as they pose replication challenges. 
This led to a decreased expression of ribosomal components resulting in impaired cellular functions 
and regenerative capacity, highlighting the role of replicative stress in age-related declines. 
Although the exact mechanisms by which genomic instability affect regenerative capacities are still 
being elucidated, extensive evidence points at the role of the DNA damage checkpoint network and in 
particular its key effectors, the gatekeeping tumour-suppressors p53, p16ink4a and p19/p14arf. They 
function by promoting cell cycle arrest, apoptosis and senescence. Therefore, while constituting 
powerful antitumourigenic mechanisms, they tend to negatively affect stem/progenitor cell function.  
As with DNA damage, their expression or function increases with age [66,68–71]. p16ink4a is an 
essential effector of cellular senescence which has been linked to the promotion of aging phenotypes 
including the decline in regenerative capacity in a variety of cell types such as muscle, brain and bone 
marrow (see discussion on the role of senescence below). In contrast, the functions of p19arf on 
regenerative processes are less well-defined; however, it is thought to act by regulating the tumour 
suppressor p53. 
Named “the guardian of the genome” [72], p53 is activated by DNA damage including telomere 
erosion (see below), reactive oxygen species and oncogene activation, leading to a transient cell cycle 
arrest, apoptosis or senescence depending on the severity of the stress incurred [73]. Many reports 
suggest that an increase in p53 expression or activity levels can lead to aging and reduced lifespan, and 
lead to stem cell death in response to telomere attrition [74–76]. Mice carrying a hyperactive mutant 
form of p53 exhibit high levels of cellular senescence in various tissues and defects in the HSC 
compartment [77,78]. In line with these observations, the elimination of p53 in mice that exhibit short 
telomeres can rescue their defects in regenerative responses and wound healing (see below). 
Furthermore, a transient reduction in p53 activity has been recently shown to be required for the 
regeneration of full limbs in salamanders, by promoting the dedifferentiation of adult cells to generate 
progenitors for regeneration [50]. Together, these findings show that p53 is important for the regulation 
of regenerative potential across various regeneration modalities (natural reprogramming and stem cell-based 
regeneration), and suggest that increases in p53 activation, such as that frequently found in aged 
tissues, are detrimental for regeneration. However, there is also evidence suggesting that p53 can be 
beneficial to regenerative processes, including observations in mice carrying an additional copy of the 
intact p53 locus. Surprisingly, these mice show a delayed onset of aging, extended lifespan and normal 
regeneration and wound healing phenotypes [79,80]. These seemingly conflicting results are likely to 
be related to the fact that the functions of p53 are highly dependent on its dose, activation status and 
kinetics, something that extends to other important gatekeepers and should be considered when 
interpreting findings and devising strategies to promote regeneration. Lastly, it should be noted that 
even though p53 inactivation could deliver improvements in regenerative capacity, these are 
outweighed by the associated risks in cancer development. Further studies focussing on the control of 
particular molecular functions by this important tumour suppressor, as well as studies in organisms 
such as salamanders, which can successfully modulate p53 to increase their regenerative potential without 
increasing cancer risk, will shed light on the mechanisms by which p53 impacts on regeneration and open 
avenues for therapeutic exploration. 
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3.2. Telomere Shortening 
A particular type of genomic instability that has been linked to the decline in regenerative capacities 
upon aging is telomere attrition. Telomere shortening, initially associated with the triggering of 
replicative senescence in proliferating cells in vitro [81], has been also observed in vivo during normal 
mammalian aging [82], in a number of regenerative cell types such as hair follicle [83] and 
hematopoietic stem cells [84]. 
Telomeres are tracts of multiple nucleotide repeats, highly conserved through evolution, and located 
at chromosome ends [85,86]. They associate with a number of proteins, such as the shelterin complex [87], 
forming a cap that prevents the activation of the DNA damage response, which could otherwise lead to 
widespread genomic instability driven by chromosome breakage-fusion events [88]. Telomere length is 
commonly maintained by the cellular retrotranscriptase telomerase, an RNA-dependent DNA polymerase 
capable of replicating telomeres and thus overcoming the end-replication problem posed by linear 
telomeric sequences [89]. Whilst high in cells of the germ line, largely due to their elevated levels of 
telomerase, telomere length decreases progressively with each cell cycle round in somatic cells, acting 
as a bona fide molecular clock. When telomeres become too short, they elicit a strong DNA damage 
response that results in apoptosis or cellular senescence. Hence, telomere attrition poses a serious 
mechanistic problem for highly proliferative cells including regenerative and cancer cell types. For this 
reason, stem and progenitor cells, with their need for extensive replication, are particularly vulnerable 
to telomere shortening. Indeed, in humans, telomere attrition is associated with a number of disorders 
that lead to loss of regenerative capacity, including dyskeratosis congenita, a progeroid syndrome that 
originates from a mutation in a key component of the telomerase complex, DKC1, and results in the 
inability to reconstitute the bone marrow [90]. 
Observations in mouse models further support the role of telomeres as important factors underlying 
the decline in regenerative capacity with aging. Genetic disruption of the gene encoding the RNA 
component of telomerase (Tertc) leads a severe degenerative phenotype characterised by stem cell 
depletion, impaired responses to tissue injury and functional damage in a variety of tissues [91]. 
Defects in proliferation are found in epidermal stem cells, loss of self-renewal and differentiation 
impairments are observed in neural stem cells, and increases in apoptosis lead to depletion of intestinal 
stem cells [92–94]. As suggested, telomere shortening could provide unrepaired DNA damage signals 
that result in the activation of gatekeepers leading to cell cycle arrest, apoptosis or senescence. In 
agreement with this, the phenotype of mice with short telomeres (Tertc−/−) can be overcome by genetic 
disruption of p53. This results in a significant increase in proliferative abilities, a decrease in apoptosis, 
and improved wound healing responses and functionality in various tissues such as intestines, skin and 
the haematopoietic system [95,96]. Nevertheless, such mice exhibited an increased tumour incidence.  
In stark contrast, the cross of wild type and late generation Tertc−/− mice results in healthy offspring, 
suggesting that both the telomere-dependent chromosomal instability and premature aging phenotypes 
can be reversed. Indeed, recent studies show that telomerase reactivation can reverse tissue 
degeneration in mice with shortened telomeres [97], and improve wound healing as well as 
regenerative responses in the mouse heart [98]. In this context, an important question is whether an 
increase in telomerase activity would, like p53 deletion, promote regenerative processes at the expense 
of cancer promotion. Notably, elevated telomerase activity has been reported in highly regenerative 
Int. J. Mol. Sci. 2015, 16 25403 
 
 
vertebrate species such as sea urchins and planarians, species in which tumour formation is rarely 
observed [99,100], suggesting that active telomere extension could contribute to extend regenerative 
capacities upon aging, and do so in a tumour-free manner. Moreover, recent studies in mice suggest 
that constitutive telomerase expression does not increase cancer risk [101]. Together, these 
observations have highlighted the relevance of telomere maintenance for the preservation of 
regenerative capacities during aging, and reignited interest in the development of therapeutic strategies 
designed to restore telomere integrity and hence promote regenerative capacity upon aging. 
3.3. Mitochondrial Dysfunction and Oxidative Damage 
Increases in mitochondrial dysfunction and bioenergetic deficiencies are characteristic of the aging 
process. Several studies have highlighted a connection between mitochondrial dysfunction and  
age-related declines in mammalian regeneration, however the identification of the relevant 
mitochondrial mechanisms has been difficult due to the multifunctional nature of these organelles: they 
constitute a vital metabolic centre, they serve as the primary sources of ROS, and play key roles in apoptosis. 
Early studies led to the formulation of the mitochondrial free radical theory of aging, whereby the 
dysfunction of the respiratory chain results in increase production of ROS, which causes further 
deterioration, damage of the mitochondrial genome, and global cellular impairment [102]. Even though 
numerous studies support a role for ROS accumulation in age-related deterioration, recent observations 
have challenged this theory. For example, increasing mitochondrial ROS or oxidative damage does not 
result in accelerated aging in mice [103], and long-lived mammals such as the naked-mole rat exhibit 
high levels of ROS and oxidative damage [104]. Furthermore, ROS have recently emerged as 
important signals for regenerative responses in highly regenerative organisms, such as hydra, 
drosophila, planarians, zebrafish and amphibians [105,106]. It is now clear that they serve as one of the 
earliest signals for the recruitment of the immune components to sites of injury, enabling wound 
detection and subsequent regeneration. Moreover, they have been shown to modulate key regenerative 
pathways, promote proliferation of progenitors for the regenerate (in many cases compensatory, following 
ROS-mediated cell death induction) and even contribute to differentiation events [107–111]. In 
mammals, ROS can recruit stem cells to proliferate or differentiate [112]. Thus, rather than hindering 
regenerative responses, the right levels of ROS may in fact be critical for their success. 
In addition, subsequent work suggests that mitochondrial dysfunction does affect aging, but that the 
accumulation of mutations in the mitochondrial genome constitutes the critical mechanism. Mice 
carrying a mutation in the proofreading domain of the mitochondrial polymerase, polymerase g [113], 
accumulate mutations in their mitochondrial DNA during development and this causes early-onset 
stem cell dysfunction and a premature aging phenotype [114]. Interestingly, the effects on stem cell 
populations vary according to the tissue. In the haematopoietic system, blocks in differentiation and/or 
disappearance of the haematopoietic progenitors are observed, leading to anaemia and lymphopenia, 
but there is no impact on HSC [115]. On the other hand, there is an impact on neural stem cells, as 
reflected by loss of quiescence and decrease in self-renewal capacities [116]. Together, these 
observations suggest that mitochondrial dysfunction could potentially accelerate aging and impact 
regenerative capacity but through a mechanism related to mitochondrial DNA mutation rather than ROS. 
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However, these findings do not exclude that ROS may still play a role downstream of the 
mitochondrial mutations in certain contexts as, notably, defects in neural stem cells and haematopoietic 
progenitors can be rescued by treatment with the antioxidant N-acetyl-L-cysteine [116]. It is possible 
that mitochondrial mutations may eventually lead to defects in the electron transport chain that could 
increase ROS levels in the affected cells. ROS could then trigger stress responses such as apoptosis, 
senescence and functional changes leading to stem cell dysfunction. In agreement with this, 
accumulation of oxidative damage has been observed in mice and human HSC after serial 
transplantations, which leads to expression of cell cycle inhibitors and premature senescence, causing 
loss of stem cell function [117]. 
Alternatively, mitochondrial mutations could impact on regenerative abilities independently of 
changes in the oxidative environment, through affecting proteins involved in apoptotic or intracellular 
signalling in stem cells or their niches [3,118,119]. In addition, a recent study suggests a role for the 
mitochondrial unfolded protein response (mtUPR) in stem cell aging (see below). It is clear that many 
questions abound on the mechanisms by which mitochondrial dysfunction impact on regenerative 
abilities, their hierarchical structure and interconnectivity, which future research should addressed. 
3.4. Epigenetic Modifications 
Changes in the epigenome such as DNA methylation and post-translational histone modifications 
are frequent during aging and have recently emerged as potentially critical factors contributing to age-
associated decline in regenerative abilities [120]. The susceptibility of epigenetic modifications to 
intrinsic as well as extrinsic signals indicates that they could act as a point of convergence for many 
processes that impair regeneration upon aging. Furthermore, the reversible nature of these changes has 
heightened the interest in this area from a therapeutic perspective. 
Large-scale changes in DNA methylation during aging have been reported for a number of species 
including human, mouse and rat [121–123]. While the observed tendency is a global decrease in 
methylation upon aging, the opposite is seen in certain genomic regions such as CpG islands, which 
exhibit hypermethylation with time [121]. This has also been observed in MSC following replicative 
senescence [124]. Some of these hypermethylated sequences are found within gene promoters, leading 
to alterations in gene expression that result in phenotypic changes and could impact on the regenerative 
capacity of a cell. Indeed, as mouse HSC age they accumulate changes in DNA methylation which 
could affect their self-renewal and differentiation abilities [65,125]. In support of this idea, modulators 
of DNA methylation are required for the function of many adult stem cells [126–130]. Furthermore, 
epigenetic regulation plays central roles during regeneration of complex structures, as demonstrated by 
experiments in the zebrafish fin, where loss of H3K27me3 is required for the initiation of the regenerative 
response [131], and in the cricket leg, where regulation of methylation/demethylation cycles are 
involved in leg patterning [132]. 
Age-related alterations in histone modifications, in particular methylation and acetylation, have 
been found in many contexts, from flies to humans. Their importance for regenerative processes is 
highlighted by studies modulating members of the sirtuin family of histone deacetylases, which have 
evolutionarily conserved roles in lifespan extension. For example, the expression of the mitochondrial 
sirtuin SIRT3 is downregulated during HSC aging, coinciding with defects in regenerative capacities. 
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Strikingly, SIRT3 upregulation in these cells can revert the age-associated decline [133]. In addition, 
SIRT6 has been shown to confer protection from telomere and replicative stresses, preventing 
decreases in regenerative capacity in endothelial cells [134], while SIRT1 has been shown to prevent 
the onset of cellular senescence in multiple cell types [135]. Notably, the SIRT1 activator resveratrol 
has been shown to extend lifespan in various organisms, although whether sirtuin modulation extends 
lifespan in other organisms is controversial [136]. 
Recently, a link between epigenetic changes and the process of cellular senescence has emerged.  
In aged mouse stem cells, disruption of the Polycomb repressor complex 2 results in the de-repression 
of key senescent regulators including p16ink4a, leading to an induction of cellular senescence [59]. This 
is consistent with previous observations, reporting that downregulation of H3K27me3 (whose 
incorporation is performed by Polycomb repressor complexes) in aged pancreas correlates with 
deregulation of p16ink4a [32,33]. Furthermore, epigenetic regulation has been implicated in age-associated 
increases in p16ink4a in other stem cell compartments. Bmi1, a component of the Polycomb complex I 
that is required for the generation of self-renewing adult HSC and neural stem cells [137], can prevent 
premature senescence of neural stem cells by repressing p16ink4a and ARF [138]. This is likely to act in 
concert with Hgma2, a transcriptional regulator highly expressed in young neural stem cells whose 
expression declines with age, as its genetic disruption leads to reduced self renewal throughout the 
central nervous system through increases in p16ink4a and ARF [139]. These observations demonstrate 
that age-related epigenetic changes impact on regenerative capacity through regulating the process of 
cellular senescence (see Section 4). 
These age-associated epigenetic modifications could underlie some of the transcriptional signatures 
associated with aging, such as the dysregulation of gero-miRNAs [140], a miRNA class which has 
been shown to affect longevity in Caenorhabditis elegans [141] and Drosophila melanogaster [142] as 
well as modulating stem cell behaviour in mammals. Interestingly, miRNAs regulate a wide variety of 
DNA damage response components (reviewed in Ugalde et al. [135]), and have been shown to play 
roles in other processes that affect regenerative capacity during aging such as cell metabolism and 
cellular senescence [143]. Furthermore, miRNA regulation is important for regeneration in species that do 
not exhibit an age-associated decline in this process such zebrafish [144,145] and salamanders [146,147]. 
Lastly, it is notable that some age-associated miRNAs can also regulate epigenetic modifiers, as is the 
case of miRNA-217, which can affect SIRT1 expression [148,149]. It is therefore likely that further 
research will uncover additional links between the age-related deregulation of miRNAs and the loss of 
regenerative abilities in various species. 
3.5. Alterations in Proteostasis 
The regenerative abilities of a cell depend on the maintenance of a functional proteome. Protein 
homeostasis, or proteostasis, is achieved by an interrelated network of pathways that collectively 
regulate and monitor protein production, localisation and folding, eliminate damaged, aggregated or 
misfolded proteins, and trigger cell cycle arrest or even cell death upon severe proteotoxic stress. 
Specialised proteins called chaperones control protein folding and localisation, while the autophagy 
and ubiquitin-mediated proteasome degradation systems mediate protein elimination. Defects in these 
important mechanisms are associated with increased cellular damage and protein dysfunction [145]. 
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Critically, many studies have shown accumulation of misfolded and damaged proteins during aging, 
suggesting that the efficiency of the proteostasis machinery decreases during this process [150]. Indeed, age 
is the principal risk factor for most protein misfolding disorders [151]. In addition, most proteostasis 
mechanisms have been shown to decline with age in human and model organisms, including  
authopagy [152], the endoplasmic reticulum stress response [153], the ubiquitin-proteasome 
degradation system [154], and the mitochondrial unfolded protein stress response [64]. More recently, 
evidence has started to emerge supporting the importance of proteostasis for the maintenance of 
regenerative capacity. Studies in haematopoietic stem cells showed that deletion of the autophagy-related 
gene Atg7 leads to elevated ROS levels and HSC depletion [155,156]. Furthermore, inhibition of 
mTORC1, a potent regulator of autophagy, using rapamycin restores self-renewal and differentiation 
capacities in aged haematopoietic and intestinal stem cells. However, it is not yet clear whether 
mTORC1 inhibition exerts its anti-aging effects through the regulation of autophagy. In this 
connection, it is worth noting that mTOR activity is regulated by nutrient availability, and has also 
been implicated in the regulation of cellular senescence [157,158]. Indeed, rapamycin treatment can 
lead to considerable inhibition of cell senescence in various contexts [159,160]. It is therefore possible 
that mTOR could regulate regenerative capacity due to effects on nutrient sensing and/or cellular 
senescence, two emerging determinants of aging-related regenerative decline (see below). 
Nevertheless, a recent study has provided strong evidence supporting proteostasis dysregulation as a 
determinant of regenerative capacity declines with age [64]. Mohrin and co-workers found that the 
histone deacetylase sirtuin 7 (SIRT7) controls the mitochondrial unfolded protein response (mUPR) by 
regulating the expression of mitochondrial translation factors. By disrupting Sirt7 in mice, they showed 
that SIRT7 regulates the level of mUPR, proliferation, differentiation and reconstitution abilities in the 
haematopoietic stem cell compartment. Furthermore, they demonstrated that the levels of SIRT7 
decrease with age in HSC and that their functional defects recapitulate those induced by SIRT7 
elimination. Finally, they showed that they could rescue the defects in the aged HSC compartment by 
overexpressing SIRT7, suggesting that the age-dependent downregulation of this central mUPR 
component contributes to the age-dependent decline in HSC regenerative capacities. 
3.6. Metabolic Changes 
Mounting evidence suggests that metabolic pathways in various cell types, including stem and 
progenitor cells, change with age. In particular, signalling pathways involved in nutrient sensing such 
as the insulin-IGF-1, Akt-FOXO, AMPK and mTOR pathways, which link nutrient availability with 
other cellular functions, unsurprisingly play important roles in the maintenance of stem cell quiescence 
during aging [161]. These are also among the most evolutionarily conserved pathways involved in the 
control of aging at the organism level, from flies to humans [3]. In the case of regenerative cell types, 
age-related changes in these pathways can affect multiple cell functions. For example, deletion of the 
mTOR regulator TSC1, which enhances mTOR signalling, leads to loss of quiescence in HSC due to 
enhanced proliferation in the stem cell compartment [162]. Likewise, increased mTOR signalling leads 
to epidermal stem cell depletion through promotion of proliferation [163], which can be counteracted 
by treatment with the mTOR inhibitor rapamycin [159]. Moreover, inhibition of mTORC1 enhances 
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HSC self-renewal during aging [162] and promotes maintenance of intestinal stem cells in mouse 
through non-autonomous effects on Paneth cells [164]. 
The importance of metabolic regulation as a contributing factor to age-related decreases in 
regenerative potential is further highlighted by the effect of caloric restriction on a number of 
regenerative systems. For example, multiple cycles of fasting have been shown to improve HSC self-renewal 
and regenerative capacities, in an IGF1-dependent manner [165], while short-term caloric restriction can 
revert age-associated increases in adipose-derived stem cells [166] and leads to enhancements in 
muscle stem cell function and repair [167]. Although the molecular mechanisms that mediate the 
beneficial effects of caloric restriction are not fully understood, it is clear that the IGF1 and mTOR 
networks play important roles [168]. 
It is possible that some of the metabolic changes that take place upon aging are a consequence of 
other age-related processes, such as telomere shortening and cellular senescence. Upon induction of 
senescence, cells undergo a series of phenotypic transformations that include metabolic reshaping.  
In the case of therapy-induced senescence, cells increase the rate of glucose metabolism and ATP 
production, likely as a result of proteotoxic stress [169]. Furthermore, cells undergoing telomere stress 
due to lack of telomerase exhibit a decrease in gluconeogenesis, impaired glucose tolerance and 
mitochondrial compromise, which are reversed by telomerase overexpression [13,170]. Thus, it is 
increasingly evident that metabolic changes can be brought about by many processes that are 
dysregulated during aging. Further research should clarify the level of metabolic changes and 
interconnectivity of metabolic changes with other factors that mediate age-associated declines in 
regenerative capacity. 
3.7. Extrinsic Signals: Local, Systemic and Blood-Borne Factors 
In addition to intrinsic changes in cells that participate directly in the regenerative response, 
changes in extrinsic factors such as the regeneration microenvironment, systemic molecules and the 
immune system, have also been associated with the decline in regenerative capacity during aging. 
Age-related changes in the specialised microenvironment of stem cells, the stem cell niche, have been 
shown to affect the regenerative capacity of stem cells in various tissues, including muscle [171–173], 
intestine [174] and the central nervous system [175]. Among these, the best-characterised example is 
skeletal muscle. Muscle regeneration relies on an intricate network of interactions between the resident 
stem cells, the satellite cells, and the constituents of their niche, which include fibro-adipogenic 
progenitors (FAPS), immune cells and muscle fibres. Many molecular mediators of these interactions 
have been found to be dysregulated upon aging, leading to defects in muscle regeneration. Notably, the 
plasma membrane levels of Delta, a Notch-1 ligand, decrease in aged muscle fibres leading to defects 
in the activation of satellite cell priming and proliferation [173]. In agreement with this, forced 
activation of Notch signalling in aged mice muscle restores its regenerative potential following injury [173]. 
Together, this suggests that age-related alterations in Notch signalling in the satellite cell niche are 
responsible for the decrease in muscle regenerative potential [176]. Further investigations revealed 
that, in addition to deregulation of the Notch pathway, aged muscle fibres exhibit increased levels of 
FGF2 signalling, which drives satellite cells out of quiescence, promoting stem-cell depletion and loss 
of regenerative capacity [172]. Nevertheless, it has recently been proposed that the increase in FGF2 
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levels in aged muscle fibres constitutes a compensatory mechanism for the loss of FRFR1 activity in 
aged satellite cells, an intrinsic alteration that results in the constitutive activation of the p38 kinase 
leading to loss of asymmetric polarization/self-renewal in muscle stem cells [177]. In this connection, 
it is worth noting that p38 activation has also been linked to the promotion of cellular senescence, a 
process that is prevalent among aged muscle stem cells [59]. It is therefore possible that age-related 
p38 activation contributes to the decline in muscle regenerative abilities by both disrupting the 
asymmetric polarization of satellite cells as well as increasing their predisposition to undergo cellular 
senescence. Hence, these studies illustrate that both niche changes as well as cell intrinsic alterations 
are important determinants of the decline in regenerative abilities during aging. 
Although rather understudied, another important element of the regenerative niche that can 
influence the outcome of regenerative processes in many contexts, including aging, is the regenerating 
nerve. A transient dependence on the concomitant regeneration of the nerves is seen in many 
regenerative processes, from tissue homeostasis to the regeneration of complex structures, in both 
vertebrate and invertebrate models [178]. The importance of the nerve as a critical determinant of 
regeneration is evident during salamander limb regeneration, where denervation of a regenerating limb 
curtails the proliferation of blastema cells and thus regrowth of the structure [178]. A similar 
requirement for nerve regeneration has been observed in zebrafish fin and barbels, starfish arms and 
annelid segments [178,179]. The presence of nerves is also critical in certain mammalian regeneration 
contexts, including bone marrow HSC, hair follicle and taste bud regeneration. In the case of the hair 
follicle, the nerves act as a source of Sonic Hedgehog that determines the ability of the upper bulge 
stem cells to become epidermal stem cells [180]. In the bone marrow, the association between HSC 
and Schwann cells has been shown to be a determinant of their quiescence [181]. More recently, it was 
demonstrated that innervation regulates myocyte proliferation and heart regeneration in neonatal mice 
as well as in zebrafish [182]. These are important considerations in the light of the general decline in 
nerve regeneration observed during aging [183]. Indeed, a decline in gustatory nerve regeneration is 
associated with the impairment in taste bud regeneration in aging mammals [27]. Together, these 
considerations raise the possibility that age-related changes in nerve regeneration capacity or 
functionality contribute to declines in regenerative processes in associated tissues. 
The mechanical properties of the microenvironment are critical regulators of cell behaviour and are 
often subject to age-dependent changes. In various contexts, ageing leads to alterations in the 
composition of the extracellular matrix (ECM) which can affect stem/progenitor cell functions such as 
self-renewal, quiescence and differentiation [184]. In the case of muscle, ECM changes upon ageing 
lead to increases in myofibre stiffness [185], with consequences for satellite cell function. Changes in 
substrate elasticity regulate skeletal muscle stem cell self-renewal in culture [186]. Furthermore, recent 
studies of isolated muscle fibres suggest that the increase in stiffness in aged myofibres leads to an 
impairment in proliferative capacity of the associated satellite cells [187]. These observations highlight 
the relevance of the mechanical microenvironment as a factor that affects variations in regenerative 
capacity upon ageing. 
Besides local cues, systemic factors play critical roles in regenerative processes and are subject to 
changes during aging. The importance of the systemic environment was initially highlighted by 
grafting experiments as well as heterochronic parabiosis. Grafting of old muscle into young rats was 
shown to improve the regenerative capacity of the grafted muscle, whereas grafting of young muscle 
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into old hosts had the opposite effect, suggesting that age-related changes in the systemic environment 
impact on the ability to regenerate [188]. This notion was extended further by observations using 
heterochronic parabiosis, whereby the circulatory systems of two animals of different ages are 
conjoined. Heterochronic pairing of young and old mice results in improved regenerative capacities in 
skeletal and cardiac muscle, enhanced neurogenesis and remyelination in the old parabiont [176,189–192]. 
These observations prompted a search for the molecular factors that underlie this age-related systemic 
regulation of regenerative processes. To date, a handful of putative regulators exhibiting age-related 
alterations have been identified, including members of the Wnt [193] and TGF-β families (such as 
GDF11 [190]), cytokines such as CCL11 [192], and hormones such as oxytocin [194]. The role of 
hormones as systemic regulators of regeneration is elegantly exemplified by the phenomenon of deer 
antler regeneration, one of the fastest organogenesis processes in the natural world, which is linked to 
the annual breeding cycle and hence controlled by fluctuations in the concentration of sex hormones 
such as oestrogen [195,196] and liver-produced insulin growth factor [197]. Indeed, this 
unconventional mammalian model provided one of the earliest suggestions that life stage dependent 
fluctuations in systemic factors could act as regulators of regenerative abilities. 
Interventions that counteract age-related alterations in the aforementioned factors including 
parabiosis, pathway inhibition/activation, or systemic supplementation, lead to improvements in the 
regenerative abilities of the target tissues. However, it is worth noting that these improvements are 
partial, as these interventions are unlikely to counteract cell-intrinsic changes that impair regenerative 
abilities during aging. 
Among the systemic changes that take place during aging and could impact on regenerative  
abilities, age-related alterations in the immune system are currently attracting considerable interest.  
It is well established that highly regulated, transient immune responses play important roles in 
regeneration and tissue repair contexts, as demonstrated in various systems including the mammalian 
muscle [198,199], the zebrafish brain [200] and fin [201], and the axolotl limb [202]. The balance of 
pro-inflammatory versus anti-inflammatory components, in particular macrophages, can affect the 
regeneration outcome, with pro-inflammatory responses usually leading to tissue atrophy or fibrosis. This 
is highly relevant to mammalian aging, as this process is characterised by an increase in inflammatory 
responses [203] as well as a decrease in the functionality of the adaptive immune system [204]. Indeed,  
age-related changes in macrophages have been shown to contribute to the reduction in regenerative 
processes such as remyelination in the mammalian CNS [191]. Furthermore, an age-associated switch 
towards the production of pro-inflammatory cytokines accounts for the decline in epidermal 
regeneration in aged mammals. The threat posed by inflammatory responses during aging is further 
aggravated by the age-related accumulation of senescent cells (see discussion below), which can itself 
be promoted by chronic inflammation [205]. Senescent cells secrete a variety of pro-inflammatory 
cytokines and thus could form part of a positive feedback loop that hinders regenerative responses 
during aging. Furthermore, this accumulation of senescent cells is likely the result of failures in 
clearance mechanisms that depend on the immune system [206,207], which are thought to decline with 
age in mammals [208]. It is noteworthy that organisms such as salamanders, which do not exhibit an 
age-related decline in regenerative capacity, do not show age-related accumulation of senescent cells, 
and this is due to an effective mechanism of macrophage-dependent immunesurveillance that seems to 
be maintained throughout lifespan [209]. It would be of great interest to investigate the basis of this 
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surveillance mechanism as well as the overall characteristics of the salamander immune response, as 
this could offer insights into the success and maintenance of regenerative capacities upon aging, as 
well as inspiring therapeutic strategies for improving immune-mediated targeting of senescent cells. 
Lastly, recent research has uncovered another factor that is likely to impact on regenerative abilities 
during aging: the gut microbiota. In the past few years, there has been a major effort in defining the 
characteristics of the gut microbiota, its potential roles and its impact on its host. This has that revealed 
numerous aspects of an organism’s physiology are affected (at the local or systemic levels) by the 
composition of its gut microbiota, ranging from pathogen protection, metabolite synthesis, and 
detoxification, to the modulation of nervous, immunological and developmental processes [210,211]. 
Notably, the composition of the gut microbiota changes through the lifespan of individuals, and this  
can lead to changes in physiological processes regulated by the gut. Studies in the intestine of  
D. melanogaster have uncovered a role for the gut microbiota in the modulation of regenerative 
responses, by showing that gut bacteria promote intestinal epithelium renewal through the induction of 
intestinal stem cell proliferation [212]. This has also been suggested by recent studies in mice intestinal 
organoids [213]. Therefore, it is possible that age-related changes in the gut microbiota lead to defects 
in tissue homeostasis, repair and regeneration. In support of this idea, the studies in the fly intestine 
also revealed that age-related defects in intestinal epithelium renewal are reversed in the absence of 
indigenous bacteria [212]. Furthermore, it is worth noting that the gut flora can regulate other 
processes known to affect regenerative responses, including cell metabolism (through the regulation of 
insulin production), oxidative processes and immune system maturation and function. Although largely 
unexplored, the study of the impact of the gut microbiota on regenerative responses presents a 
promising area for future studies. 
4. A Link between Cellular Senescence, Aging and Regenerative Capacity 
In recent years, it has become clear that the process of cellular senescence underlies many aspects 
of aging [214], including decline in the capacity to sustain tissue homeostasis and regeneration. Due to 
its nature, it constitutes an important point of convergence of many factors that impair regenerative 
capacities including genomic instability, telomere attrition, epigenetic changes, oxidative damage, 
metabolic alterations, dysregulation of cellular communication and inflammation, representing an 
attractive target for therapeutic intervention. 
Cellular senescence is traditionally understood as a state of permanent cell cycle arrest accompanied 
by various phenotypic alterations, which is induced by stimuli including exposure to DNA damage, 
telomere erosion, epigenetic alteration of senescence regulators, oxidative damage and oncogenic 
stress. Although the nature of the molecular events involved in the establishment of senescence is still 
under investigation, the p53/p21 and the p16ink4a/Rb pathways have been shown to play key roles in 
most senescent settings, chiefly through their effects on cell cycle inhibition for the promotion of growth  
arrest [215–219]. Like apoptosis, senescence functions to prevent the propagation of damaged cells, 
constituting a powerful mechanism of tumour suppression. However, in contrast to apoptotic cells, 
senescent cells remain metabolically active and undergo a series of phenotypic transformations  
which include the expansion of mitochondrial and lysosomal networks (leading to high levels of  
senescence-associated-β-galactosidase (SAβgal) activity, the best-known senescent cell marker [220], 
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up-regulation of DNA checkpoint proteins such as p53, p21 and p16ink4a, rearrangements in nuclear 
architecture and heterochromatin organization, and the acquisition of a senescence-associated secretory 
phenotype (SASP) which comprises growth factors, proinflammatory cytokines, chemokines and  
matrix-remodelling proteins [221–223]. Despite their beneficial functions in tumour-suppression, 
senescent cells can have detrimental effects on biological processes. These effects can be cell intrinsic, as in 
the case of the direct abrogation of proliferative capacity or alterations in cell function, or cell 
extrinsic, such as the paracrine induction of senescence in neighbouring cells [224,225] and the 
promotion of inflammation [206], which are mediated by the SASP. In particular, these cell-extrinsic 
effects have been proposed to contribute to tissue degeneration, malfunction and decline in 
regenerative capacities. 
The negative functions of cellular senescence are of particular relevance to aging, as senescent cells 
have been shown to accumulate in various tissues (including skin, lung, liver, spleen and kidney) in 
mammals as they age [226,227]. Critically, recent evidence in mouse models established a casual link 
between the accumulation of senescent cells and a number of age-related disorders. In a seminal study 
by Van Deursen and co-workers, genetic elimination of p16ink4a+ senescent cells in mice with a 
progeroid background caused by BubR1 deficiency was able to delay the onset of age-related disorders 
including cataracts, sarcopenia, osteoporosis and subcutaneous fat loss [228]. These results imply that 
cellular senescence is an important contributor to age-related decay. Furthermore, they suggest that 
removal of senescent cells could prevent or delay tissue dysfunction and extend healthspan [214,228]. 
With regards to cell types involved in regenerative processes, the accumulation of senescent 
progenitor (i.e., endothelial progenitor cells) or stem cells (i.e., HSC, satellite cells, NSC) has been 
observed in vivo during mammalian aging and in progeroid syndrome mouse models. As so far there is 
no unambiguous senescence marker available, all observations are based on the combined detection of 
various senescent cell markers, such as SAβgal, lack of proliferation markers,γ H2AX foci and p16ink4a 
protein levels [229]. Of these, many studies have focused on p16ink4a expression, as it is both a marker  
(found up-regulated in many senescence contexts) as well as an established inducer of senescence.  
Its overexpression has been shown to contribute to the replicative failure of many regenerative cell  
types [69,70], while its downregulation or genetic deletion has been shown to ameliorate the age-
associated functional and proliferative impairment in stem and progenitor cells [68,230]. This led to the 
suggestion that cellular senescence could be an important factor underlying the decline in regenerative 
capacity with aging. In support of this idea, modifications that lead to cellular senescence, such as 
telomerase inhibition and nucleotide-analogue induced replicative damage, result in reduced tissue 
repair and regenerative capacities [231]. Furthermore, the aforementioned studies in the BubR1 mice 
hinted that selective elimination of p16ink4a+ senescent cells could be beneficial for regenerative 
processes, given the improvements observed in epithelium structure and sarcopenia [228]. More 
recently, direct evidence of the role of senescence as a key mediator of age-related decline in 
regenerative capacities came from studies in mouse muscle regeneration, which revealed that geriatric 
muscle stem cells loose their reversible quiescent state during aging by undergoing cellular senescence 
(Figure 4) [59,232]. This switch, which renders cells unable to activate and expand upon muscle 
injury, is brought about by an age-related increase in p38 pathway activity and the loss of polycomb 
repressive complex activity, which result in increased p16ink4a expression and senescence induction. 
Importantly, pharmacological inhibition of p38 or specific silencing of p16ink4a in geriatric satellite 
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cells restores both their reversible quiescence and regenerative functions [59,232]. These studies 
suggest that maintenance of the quiescent state relies on the active repression of senescence pathways, 
and that cellular senescence is a major contributor to the age-related decline in regenerative abilities. 
 
Figure 4. Impact of cellular senescence on regenerative processes during aging. Senescent 
cells accumulate in most organisms as they age, and this can negatively affect various 
regenerative processes. In the case of aged mammalian stem cells such as satellite cells 
(A), an age-associated switch to cellular senescence leads to loss of quiescence resulting in 
impaired regenerative ability; In addition to direct effects on regenerative capacity, 
senescent cells could promote tissue disruption, inflammation and niche or systemic 
alterations (B) through their phenotype (SASP), leading to further regenerative impairment; 
Senescent cell accumulation through aging can result from increases in stimuli that trigger 
cellular senescence (e.g., ROS, DNA damage, telomere attrition) or impairments in the 
immune-mediated clearance mechanism. In contrast to mammals, salamanders (C) have 
highly efficient mechanisms of senescence immunesurveillance which prevent senescent 
cell accumulation and could support their extensive regenerative abilities through lifespan. 
Besides the direct impact of cellular senescence on stem cell quiescence, this process could affect 
regenerative capacities indirectly (Figure 4), through the promotion of tissue degeneration, malfunction 
and inflammation, brought about by the senescence-associated phenotype (SASP). These processes 
could lead to niche and/or systemic alterations in the regenerative environment that result in 
impairments in regenerative abilities. In addition, it is possible that particular components of the SASP 
could impact on the regenerative cell types directly and affect their regenerative potential or function. 
The association of cellular senescence with negative outcomes at the organism level has recently 
revived discussions on its evolutionary rationale. Even though cellular senescence has tumour-suppressor 
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functions that could explain its persistence, so does apoptosis. Moreover, apoptosis could be 
considered a more effective mechanism, as it involves direct elimination of the target cells. It is 
possible that the negative effects of cellular senescence are manifested mainly during the post-reproductive 
period, and hence escape the challenges of selection. Alternatively, it is conceivable that senescent cells 
play positive roles in physiological contexts. In support of this view, the transient induction senescent 
cells have recently been found to contribute to tissue remodelling during mouse embryonic 
development [233,234], wound healing [235,236], and fibrosis restriction in organs such as liver [237] 
and heart [238]. Though distinct, these processes are each relevant to tissue regeneration. Therefore, it 
is possible that cellular senescence, when induced transiently, could play positive roles in regenerative 
responses. Although this suggestion has not yet been addressed directly, studies in the salamander limb 
regeneration model have recently offered significant insights. These investigations revealed that 
senescent cells are recurrently induced during the intermediate stages of regeneration, coinciding with 
the period of generation/expansion of regenerative progenitors, and are subsequently eliminated by a 
highly effective mechanism of senescence immunesurveillance dependent on macrophages [209]. 
Interestingly, senescent cells are not induced during normal limb development in this model, indicating 
that this phenomenon is specific to regeneration. The implications of these findings are varied. First, 
they constitute the first report of senescent cell induction during regeneration, and open the door to 
analysing whether transient induction of cellular senescence contributes to regeneration, an important 
future direction for both the Aging and the Regeneration fields. This has significant therapeutic 
implications for the design of anti-aging or regenerative strategies that target senescent cells: were they 
to play a positive role at certain stages of regeneration, their targeting should be avoided during that 
period. Second, they uncovered a new, highly efficient mechanism of immune surveillance that 
operates in normal and regenerating tissues, which correlates with a lack of age-related accumulation of 
senescent cell in salamanders (Figure 4). This mechanism has been proposed to support the ability of 
this organism to undergo regeneration throughout its lifespan [209]. Its study could deliver new 
approaches for the elimination of senescent cells to promote regenerative processes and healthspan 
improvement in organisms such as humans. 
5. Avenues for Therapeutic Interventions 
The advances in our understanding of the factors that modulate the decline in regenerative abilities 
have pinpointed areas of potential clinical relevance. At present, therapeutic strategies that counteract 
defects in regenerative capacities are somewhat lacking. In any case, in designing such strategies, the 
type of regeneration to be improved (whether it is tissue turnover or structural replacement), the 
defects to be overcome, the cell types to be regenerated and the characteristics of the regeneration 
niche should be considered. 
Although it could be argued that transplantation of stem cells could constitute a viable and clinically 
relevant option in various contexts, it faces many challenges such as the acquisition and survival of 
sufficient quantities of cells for the process, immunocompatibility and cancer risk issues, and the fact 
that transplantation of young cells may not be able to overcome extrinsic influences that could underlie 
the decay in regenerative abilities in an aged host. Hence, addressing the particular alterations in the 
processes that drive age-related regenerative decays could represent a more fruitful alternative. This 
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would involve the specific targeting of extrinsic and intrinsic factors (and, most likely, a combination 
of them), taking into account tissue/system/timing specific requirements, and balancing the benefits for 
the organism against secondary outcomes associated to each manipulation. Various approaches have 
emerged from studies in experimental models (Figure 5), however they differ in their capacity to 
improve regeneration, the secondary effects associated to them and thus their therapeutic promise. For 
example, even though the manipulation of certain pathways involved in the maintenance of genome 
stability (i.e., p53, p16ink4a) and telomerase reactivation represent powerful strategies for counteracting 
the loss of regenerative abilities upon aging, the associated risk of tumourigenesis represents a big 
caveat to their application. In contrast, systemic approaches such as caloric restriction, excersise and 
controlled modulation of key metabolic pathways such as mTOR, Igf1 and sirtuins hold better 
therapeutic prospects. In addition, much emphasis has recently been put on the use of systemic factors 
for the promotion of regeneration (e.g., GDF11). Although these certainly have good potential, further 
studies are required in order to start considering their application in a clinical setting. 
 
Figure 5. Therapeutic strategies for improving regenerative capacity. 
In light of recent discoveries, a strategy that has aroused considerable interest within the Aging field 
is the selective elimination of senescent cells [214]. Studies in mouse models have shown its potential 
as a means to enhance regenerative abilities [59,232] as well as to improve a number of age-associated 
pathologies [228]. However, senescent cell clearance has so far been achieved, in most cases, through 
genetic ablation of senescent cells based on p16ink4a expression. Although p38 inhibition in pre-senescent 
cells could constitute an alternative [232], p38 functions are so ubiquitous that it is unlikely that p38 
inhibitors could be broadly used, unless they are applied to isolated regenerative sub-types. These 
considerations have led to the search for “senolitics”, molecules that selectively promote the 
elimination of senescent cells. Progress has been made with the recent finding that a combination of such 
compounds, dasatinib and quercetin, leads to improved senescent cell elimination in a mouse model [239]. 
However, its effects on regenerative abilities (and many other physiological processes) were not 
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evaluated in this study and remain to be tested. Alternatively, it is possible that senescent cell 
elimination can be achieved by the promotion of their natural mechanism of destruction, which 
consists of elimination through immunesurveillance [206]. Although there are at present no means to 
achieve this, the recent finding of a highly efficient immune mechanism of senescent cell clearance in 
the archetypical regeneration model, the salamander [209], has opened up new possibilities for 
exploring this alternative. 
Multiple clinical approaches, targeting some of the key factors that affect regenerative capacity 
upon aging, have been proposed for the improvement of regenerative processes in mammals. These are 
based on the elimination of damaged cells (e.g., senescent cell clearance) or the improvement of regeneration 
potential in regenerative cell types (e.g., epigenetic reprogramming). They may also result in decreased 
inflammation and reduced fibrosis during tissue repair. Therapeutic applications are likely to involve 
combinatory approaches, counteracting the effect of both cell-intrinsic as well as cell-extrinsic factors. 
The lack of information on the physiological consequences of certain manipulations, though 
attractive, represents a barrier to their implementation. This includes the reversion of epigenetic 
changes through induced reprogramming to pluripotency. This strategy has been successfully used to 
reprogramme aged haematopoietic progenitors [240] and T cells [241,242], and the resulting iPSC 
were differentiated following expansion into the respective cell types, leading to “rejuvenated” 
haematopoietic or lymphocyte populations. However, it is unclear what the long-term consequences of 
these plasticity changes are, whether they cause any impairment in cellular function or even increase 
cancer propensity. Likewise, it is not clear if reprogrammed cells are indeed rejuvenated [243]. These 
issues should be addressed by future research in order to unlock the potential of reprogramming as a 
therapeutic strategy for improving regenerative processes. 
These observations have raised questions such as what is the nature of rejuvenation in molecular 
terms, and whether any of the modifications discussed herein can actually induce cells to revert to a 
more youthful status [244]. These issues are also pertinent in the context of super-regenerator 
organisms such as salamanders, which can regenerate complex body parts multiple times throughout 
their lives, without any decay in regenerative abilities. Do they exhibit mechanisms to induce reversion 
to a more youthful cellular state? This question needs to be considered in the light of the regenerative 
strategy used by these organisms, as it differs from the unidirectional stem cell-based regeneration seen 
in mammals. In salamanders, the main regenerative strategy is partial dedifferentiation (a type of limited 
reprogramming) of adult cell types followed by extensive proliferation and redifferentiation [48,245]. 
This process involves the reversion of certain epigenetic modifications [246,247], but whether 
dedifferentiation is able to revert aged adult tissues to a youthful status is unknown. In this connection, 
it is worth noting that newt lens regeneration, an age-resistant process, takes place by transdifferentiation of 
somatic cells [51]. Interestingly, it has been observed that this process involves a step of 
dedifferentiation and expression of pluripotency genes such as Sox2, c-myc and Klf4 [248], and this 
could represent a reversion of age status. Certainly, it is possible that the nature of the regeneration 
strategy, combined with effective mechanisms to overcome processes that negatively impact on 
regeneration in other systems, such as cellular senescence [209] and possibly others, could explain this 
remarkable ability to withstand aging and age-related declines in regenerative capacity. This a 
possibility that should be addressed by further studies, as it has significant implications of fundamental 
and therapeutic nature. 
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In this context, it is also interesting to consider other extreme regenerators such planarian flatworms, 
which are able to achieve whole body regeneration through a stem cell based mechanism [38,249].  
In contrast to mammalian stem cells, a single planarian neoblast (the planarian stem cell) has the 
potential to reconstitute the entirety of planarian tissue types [250]. This raises further questions, such 
as what underlies the extreme potency of planarian stem cells, how this is related to their apparent 
immortality, and whether they share any strategies for the preservation of cellular and genomic 
integrity with germ cells. Together, these considerations illustrate that much is yet to be learned from 
these powerful regeneration models regarding how to promote effective regeneration throughout 
lifespan. Undoubtedly, this constitutes a promising area for future studies. 
6. Conclusions 
The ability to regenerate tissues and organs is widespread across the animal kingdom. However,  
there are marked changes in regenerative capacity through phylogeny, ontogeny and aging. Whilst a 
number of organisms exhibit extensive regenerative faculties which do not decline through their lives,  
a progressive decay in the capacity to undergo regenerative processes is observed as most organisms 
age. A considerable number of factors contribute to this decline in regenerative ability. Their extensive 
overlap with the recently defined “Hallmarks of Aging” highlights the interrelated nature of the 
dwindling of regenerative capacities and the process of aging. Establishing the relative importance of 
such factors, the extent of their effects on different regeneration systems, the degree of 
interconnectivity between them and the points of convergence will be crucial for understanding the 
nature of age-related regenerative declines and designing fruitful therapeutic strategies to overcome 
them. It is becoming increasingly clear that certain factors, such as cellular senescence, constitute 
common denominators which impact on various regenerative systems and thus hold great promise for 
clinical intervention. However, despite the progress made so far, it is also evident that we are far from 
reaching a full understanding of the interplay between regenerative capacity and aging. Further 
research will benefit from studies in both vertebrate and invertebrate models of age-related 
regenerative decline, as well as from work in organisms where these capacities are not affected by 
aging, such as salamanders. Together, these approaches will deliver important insights into the variations 
of regenerative capacity through lifespan. 
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